4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-266433
Director sold 643 shares at $249.00 ($160,107)
- Director acquired 1,429 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2026-06-08 | Option exercise 10b5-1 | +1,429 | 31,032 | D: show line 1 in the form | ||
| Coleman Mark Director | 2026-06-10 | Sale 10b5-1 | −643 | $249.00 | $160,107 | 30,389 | D: show line 2 in the form |
| Open-market sales · 643 sh · avg $249.00 · $160,107 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2026-06-08 | Option exercise · Restricted Stock Units 10b5-1 | −1,429 | 0 | D: show line 3 in the form |
Loading xslF345X06/ownership.xml…